Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast Cancer
NCT01440413
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
BIOLOGICAL:
Blood and tumor sample
Sponsor
Centre Leon Berard